Database for New Dietary Ingredient Notifications Launches

Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava FDA/FTC Join Regulatory Efforts against Hormone-Related Product Claims The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have announced actions against a number of companies marketing unapproved “alternative hormone therapies,” targeting unproven disease claims; FDA said it has sent Warning Letters to 16 dietary supplement and hormone cream marketers; FTC is issuing letters that notify 34 websites that include unsubstantiated claims. FDA/FTC Join Regulatory Efforts against Hormone-Related Product Claims The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have announced actions against a number of companies marketing unapproved “alternative hormone therapies,” targeting unproven disease claims; FDA said it has sent Warning Letters to 16 dietary supplement and hormone cream marketers; FTC is issuing letters that notify 34 websites that include unsubstantiated claims. FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims Federal Trade Commission staff sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these sellers that their marketing claims may be illegal. FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims Federal Trade Commission staff sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these sellers that their marketing claims may be illegal. ICS Inc. continues to expand In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris. ICS Inc. continues to expand In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris. ICS Inc. continues to expand In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris. ICS Inc. continues to expand In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris. ICS Inc. continues to expand In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris. ICS Inc. continues to expand In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris. AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65 AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer. AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65 AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer. AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65 AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer. AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65 AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer. AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65 AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer. AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65 AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer. FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. FSANZ Invites Comment About Draft Health Claims Standard Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Report on the Codex Nutrition Committee Meeting in Bonn, Germany Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model' Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Bi-national Food Agency Wants Comment on Proposed Changes to Regulations Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food. Bi-national Food Agency Wants Comment on Proposed Changes to Regulations Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food. FDA Acts to Seize Ephedra-Containing Dietary Supplements The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon. FDA Acts to Seize Ephedra-Containing Dietary Supplements The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1 The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)). Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1 The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)). Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. FDA Acts to Protect Public from Fraudulent Avian Flu Therapies Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza. FDA Acts to Protect Public from Fraudulent Avian Flu Therapies Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. Canada- Recall of Chaparral-Containing Products Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns. Canada- Recall of Chaparral-Containing Products Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula	Searchable AHPA NDI Database Developed by AHPA and NPIcenter The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database to access all notifications the Food and Drug Administration (FDA) has received for new dietary ingredients (NDIs). The AHPA NDI Database launches on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period begins. The database can be searched by numerous relevant fields, including the generic or brand name of every 75-day notice (botanical and non-botanical), the Latin binomial of herbs, and the name of the company that made the submission. The database also provides a concise “outcome statement” for each file that quickly summarize how FDA has responded to every notification, and the problems, if any, that the agency identified for each. “New ingredients are key to the supplement industry’s future and the AHPA NDI Database will be a valuable resource for firms that are filing the required notification prior to marketing an NDI, said Michael McGuffin, president of AHPA. “By accessing and reviewing other relevant NDI notifications, companies will be better prepared to file complete submissions and thereby prevent delays to market entry.” The Dietary Supplement Health and Education Act (DSHEA) requires manufacturers or distributors of an NDI — an ingredient not sold before DSHEA went into effect in 1994 — to provide information to FDA that is the basis for a conclusion that the ingredient is reasonably expected to be safe (New dietary ingredients that are articles used as food in a form in which the food has not been chemically altered are exempt form the notification requirement described here.). Since DSHEA passed, FDA has posted almost 300 NDI notifications on its dockets website. However, the only organization provided is by the FDA-assigned report numbers, which makes individual reports very difficult to locate. Even when found, it is impossible to know without opening and examining the entire file (which can run to hundreds of pages) whether a filing was successful or whether (and why) FDA objected to the notification. The AHPA NDI Database was specifically designed to provide faster and more informative access to filed notifications. The database will be maintained on an ongoing basis; future NDI filings and FDA responses will be promptly added to the system. Special introductory access fees for AHPA members are $125 per year per site / $40 per day per site, and for non-members are $495 per year per site / $125 per day per site. The open-access trial period runs 9 a.m.–6 p.m. Eastern, Monday, December 5, only. The AHPA NDI Database is accessible at http://ndi.npicenter.com/.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software